Patents by Inventor Mukta M. Webber

Mukta M. Webber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immortalized and malignant human prostatic cell lines
    Patent number: 6255058
    Abstract: Immortalized malignant human prostatic epithelial and fibroblast cell lines containing DNA of a human papillomavirus (HPV) and similar cell lines containing DNA of a human papillomavirus and an activated viral ras oncogene, such as v-Ki-ras. The cell lines are useful for research on drugs for treatment of prostatic cancer and other diseases. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents.
    Type: Grant
    Filed: October 14, 1998
    Date of Patent: July 3, 2001
    Assignees: Board of Trustees operating Michigan State University, The United States of America as represented by the Department of Health and Human Services
    Inventors: Mukta M. Webber, Johng S. Rhim
  • Immortalized and malignant human prostatic cell lines
    Patent number: 5824488
    Abstract: Immortalized malignant human prostatic epithelial and fibroblast cell lines are described containing DNA of a human papillomavirus (HPV) and similar cell lines containing DNA of a human papillomavirus and an activated viral ras oncogene, such as v-Ki-ras. The cell lines are useful for research on drugs for treatment of prostatic cancer and other diseases. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: October 20, 1998
    Assignees: Board of Trustees operating Michigan State University, The United States of America as represented by the Deparmtent of Health and Human Services
    Inventors: Mukta M. Webber, Johng S. Rhim
  • Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
    Patent number: 5814452
    Abstract: Immortalized non-tumorigenic or tumorigenic human prostatic epithelial and fibroblast cell lines and derivatives thereof, containing DNA of a hybrid virus between adenovirus 12 and simian virus 40. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: September 29, 1998
    Assignees: Board of Trustees operating Michigan State University, The United State of America as represented by the Department of Health and Human Services
    Inventors: Mukta M. Webber, Johng S. Rhim
  • Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
    Patent number: 5716830
    Abstract: Immortalized non-tumorigenic or tumorigenic human prostatic epithelial and fibroblast cell lines and derivatives thereof, containing DNA of a hybrid virus between adenovirus 12 and simian virus 40. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents.
    Type: Grant
    Filed: February 25, 1997
    Date of Patent: February 10, 1998
    Assignees: Board of Trustees operating Michigan State University, The United States of America as represented by the Department of Health and Human Services
    Inventors: Mukta M. Webber, Johng S. Rhim
  • Human prostatic cell lines immortalized by adenovirus 12-simian virus 40 (AD12/SV40) hybrid virus
    Patent number: 5610043
    Abstract: Immortalized non-tumorigenic or tumorigenic human prostatic epithelial and fibroblast cell lines and derivatives thereof, containing DNA of a hybrid virus between adenovirus 12 and simian virus 40. The cell lines are useful for research on causes, treatment and prevention of prostate cancer, benign prostatic hyperplasia, male infertility, birth defects, aging and assessment of environmental toxic agents.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: March 11, 1997
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Mukta M. Webber, Johng S. Rhim